Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luteolin is a naturally occurring flavonoid found in many plants, including celery, parsley, and chamomile. It exhibits a wide range of pharmacological activities such as anti-inflammatory, antioxidant, neuroprotective, analgesic, anti-allergic, antibacterial, antiviral, apoptosis-inducing and chemopreventive effects[1][3][4][8]. Mechanistically, luteolin acts by inhibiting key inflammatory mediators (such as Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Mitogen-activated protein kinase (MAPK) pathways), reducing oxidative stress through direct scavenging of Reactive oxygen species (ROS) and activation of antioxidant enzymes[1][5][6]. It also modulates the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT pathway) and enhances transepithelial sodium transport in lung tissue[5], interacts with GABAA receptor for analgesic effects[1], suppresses cAMP-phosphodiesterase activity to reduce inflammation[5], and can induce apoptosis in tumor cells while protecting normal cells from oxidative damage[6]. Luteolin has been studied preclinically for chronic inflammatory diseases (e.g., rheumatoid arthritis), neuropathic pain conditions, respiratory diseases like COPD and ARDS/ALI[1][5], viral infections including COVID-19[8] and RSV pneumonia[5], as well as cancer prevention. While it shows promise for these indications due to its safety profile in preclinical studies,[1] further clinical trials are needed to establish efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on luteolin.